dihydroethidium has been researched along with ezetimibe in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 2,484 | 563 | 1,465 |
| Protein | Taxonomy | dihydroethidium (IC50) | ezetimibe (IC50) |
|---|---|---|---|
| NPC1-like intracellular cholesterol transporter 1 | Homo sapiens (human) | 0.37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanayama, R; Hayashi, H; Koriyama, H; Mori, M; Morishita, R; Nakagami, H; Osako, MK; Shimizu, H; Takami, Y | 1 |
1 other study(ies) available for dihydroethidium and ezetimibe
| Article | Year |
|---|---|
Vascular protective effects of ezetimibe in ApoE-deficient mice.
Topics: Animal Feed; Animals; Anticholesteremic Agents; Apolipoproteins E; Azetidines; Cholesterol, HDL; Dietary Fats; Ethidium; Ezetimibe; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Nitric Oxide Synthase Type III; Oxidative Stress | 2009 |